The
computational biology market is predicted to have a notable growth
owing to its wide use by biotechnology and pharmaceutical companies
to reduce the incidences of late stage failures of their drugs and
thereby curb R&D expenditure. This market involves application of
biology and information technology field for drug discovery and drug
development. Computational biology also assists in reducing extensive
use of human in clinical trials and is therefore useful for pediatric
trials, trials on pregnant women and orphan disease research. The
computational biology market has witnessed significant growth in the
past due to rise in late stage drug failure coupled with its ability
to reduce extensive use of humans in clinical trials.
Get
Computational Biology Industrial Outlook:
This
report provides an in-depth and comprehensive analysis of the
computational biology market on the basis of application, tools and
by services. This report studies the global market for computational
biology through the perspective of cellular modeling and disease
modeling. In application segment, the report covers cellular &
biological simulation and disease modeling and simulation application
or CADD (Computer Aided Drug Design). Cellular & biological
simulation market has also been segmented on the basis of
computational genomics, computational proteomics, pharmacogenomics
and others (transcriptomics/ metabolomics). Disease modeling and
simulation segment is categorized into drug discovery and drug
development. The market of drug discovery is divided into target
identification, target validation, lead discovery and lead
optimization. Drug development market is segmented as preclinical,
clinical trials and human body simulation software. The market of
clinical trials is studies based on phase I, phase II and phase III
trials.
The
market of computational biology market, by tools is categorized into
database, IT infrastructure (hardware) and analysis software and
services types. The computational biology services market highlights
the trend of in-house computational biology and external or contract
computational biology. The report also provides various types of
technological advancements taking place in each segment. All the
above mentioned segments are analyzed on the basis of market size in
terms of USD million and their forecasts for the period 2012 to 2018
have also been provided. The CAGR (%) for each market segment has
been estimated for the forecast period 2012 to 2018, considering 2011
as the base year. In addition, this report covers participation of
different organizations of the U.S. and the U.K. for the development
of computational biology market.
Computational
Biology Market Description:
The
market is also forecasted in terms of value (USD million) for the
period 2012 – 2018 for four major geographic regions, namely North
America, Europe, Asia-Pacific and Rest of the World (RoW). Market
sizes, forecasts and % CAGR for each region have been provided in
geography segment. A detailed qualitative analysis of the factors
responsible for driving and restraining the growth of the
computational biology market and future opportunities are covered in
the report. Moreover, a PESTLE analysis has been done while
estimating individual geographies in order to provide current as well
as future status. A list of recommendations for existing as well as
new entrants has been discussed in the study. This recommendation
chapter provides assistance to industry players on ways to enter this
market or to establish sustainable competitive advantage.
Some
of the key market players of the global computational biology market
include Genedata AG, Nimbus Discovery LLC, Rhenovia Pharma SAS,
Certara, Chemical Computing Group, Inc., Compugen, Ltd, Simulation
Plus, Inc., Schrodinger, Leadscope, Inc., Accelrys, Entelos and
Insilico Biotechnology AG. Market players are profiled in this report
on the basis of attributes such as company overview, financial
overview, business strategies adopted by the companies to ensure
sustainability and maximize profits, product portfolio and recent
developments. The competitive landscape of this industry has been
covered under market share analysis by key players.
No comments:
Post a Comment